Mode of Administration

Mode of Administration - Axcellant

Mode of Administration

  1. Feb 28, 2025

What Does the ‘Mode of Administration’ Mean?

Mode of administration refers to the method by which a medication or treatment is delivered to a patient in a clinical trial or medical setting. It encompasses the specific route and technique used to introduce a drug or intervention into the body. Common modes of administration include oral, intravenous, intramuscular, subcutaneous, topical, and inhalation.

The chosen mode of administration can significantly impact a drug’s effectiveness, absorption rate, and potential side effects. Researchers and healthcare professionals carefully consider factors such as the drug’s properties, the condition being treated, and patient convenience when selecting the most appropriate mode of administration for a particular study or treatment plan.

Why Is the ‘Mode of Administration’ Important in Clinical Research?

The mode of administration is crucial in clinical research as it directly influences the safety, efficacy, and bioavailability of investigational drugs. It plays a vital role in study design, affecting participant recruitment, adherence to treatment protocols, and the overall success of clinical trials.

Understanding the mode of administration helps researchers accurately interpret study results and compare outcomes across different trials. It also informs decisions about drug formulation, dosing schedules, and potential commercial viability, which are essential for pharmaceutical development and regulatory approval processes.

Good Practices and Procedures

  1. Conduct thorough pre-trial assessments to determine the most suitable mode of administration, considering factors such as drug stability, target organ accessibility, and patient population characteristics.
  2. Implement standardized training programs for clinical staff to ensure consistent and accurate administration techniques across all study sites.
  3. Develop detailed, step-by-step administration protocols that include proper handling of the investigational product, required equipment, and post-administration monitoring procedures.
  4. Establish a system for documenting and reporting any deviations from the prescribed mode of administration, including reasons for the deviation and potential impacts on study outcomes.
  5. Regularly review and update administration procedures based on emerging safety data, technological advancements, and feedback from study participants and clinical staff.

Related Terms

Resources

Axcellant appointed Global CRO for Santersus’ multinational pivotal study in sepsis

Axcellant, a specialist global contract research organization (CRO), has been appointed by Switzerland-based Santersus AG to support the execution of…

Axcellant to Attend EANM 2026 in Vienna

Axcellant will participate in the Annual Congress of the European Association of Nuclear Medicine (EANM 2026), taking place from 17…

Large Language Models in Nuclear Cardiology: From Experimental Tools to Clinical Infrastructure

3 Questions with: Prof. Piotr Słomka Large language models are entering nuclear cardiology at a pace that makes the usual…